Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 38 of the 41 references it cites were found in a registry or an index; 56 of the 137 sources its claims cite were checked for support.

Endometriosis and Cardiovascular Disease: Exploring Pathophysiological Interconnections and Risk Mechanisms

Open access

Abstract

Endometriosis, traditionally viewed as a gynecological disorder, is increasingly recognized as a systemic disease with significant cardiovascular implications. Recent studies suggest that women with endometriosis are at higher risk for developing atherosclerosis and other cardiovascular diseases (CVDs), due to chronic systemic inflammation, endothelial dysfunction, oxidative stress, and metabolic disturbances. This review aimed to summarize current evidence on the vascular implications of endometriosis. A literature search was conducted in PubMed and Google Scholar, focusing on studies exploring the relationship between endometriosis and cardiovascular risk. In rare cases, endometriosis can affect extrapelvic locations such as the diaphragm or pericardium, presenting with cyclical chest pain or dyspnea and mimicking cardiopulmonary conditions. These atypical manifestations often delay diagnosis and highlight the need for heightened clinical awareness. Advances in imaging and minimally invasive techniques, including robotic surgery, have improved the detection and management of such presentations. Shared molecular pathways between endometriosis and CVDs, including pro-inflammatory cytokines and metabolic dysregulation, provide a rationale for exploring novel therapeutic approaches. Emerging pharmacologic options such as statins, metformin, or antiplatelet agents may offer dual benefits for both reproductive and cardiovascular health. Given the multifactorial nature of endometriosis, a multidisciplinary approach involving gynecologists, cardiologists, and primary care providers is essential. These findings highlight the need for early cardiovascular risk assessment and tailored preventive strategies in this population.

Overview

CoChat Summary

TL;DR

This narrative review summarizes evidence that endometriosis is associated with increased cardiovascular risk through shared inflammatory, oxidative, endothelial, metabolic, and genetic mechanisms. It also highlights rare supradiaphragmatic/pericardial endometriosis as a diagnostic mimic of cardiopulmonary disease and calls for multidisciplinary cardiovascular risk assessment in affected women.

Key findings

  • Women with endometriosis appear to have higher risks of cardiovascular disease: the Nurses’ Health Study II found a 62% higher risk of coronary heart disease, and a UK retrospective analysis reported a 40% higher likelihood of ischemic heart disease and a 26% increased risk of arrhythmia.
  • Shared mechanisms include chronic systemic inflammation, oxidative stress, endothelial dysfunction, arterial stiffness, metabolic disturbances such as insulin resistance/dyslipidemia, and overlapping genetic loci including CDKN2B-AS1 on chromosome 9p21 and 7q22.
  • Rare supradiaphragmatic endometriosis involving the diaphragm, pleura, or pericardium can cause cyclic chest pain, dyspnea, pneumothorax, or pericardial effusion and is often misdiagnosed as cardiopulmonary disease; case reports describe successful surgical and hormonal management.
  • Emerging pharmacologic options such as statins, metformin, antiplatelet agents, and beta-blockers may offer dual reproductive and cardiovascular benefits, but the review states further research is needed.

Methods

  • Narrative literature search in PubMed and Google Scholar for studies published between 2010 and 2024, using keywords including “endometriosis,” “cardiovascular disease,” “atherosclerosis,” and related terms.
  • Inclusion prioritized original research, systematic reviews, and meta-analyses in peer-reviewed journals; human studies explicitly investigating endometriosis and cardiovascular outcomes; English-language articles with sufficient methodological detail.
  • Exclusion criteria included in vitro or animal studies without clinical translation, non-peer-reviewed materials, and studies unrelated to cardiovascular outcomes or the reviewed pathophysiological mechanisms. No new data were generated and no ethical approval was required; generative AI tools assisted in identifying articles and refining search strategies.

Limitations

  • The paper states that evidence supporting a systemic inflammatory effect sufficient to drive atherogenesis is currently limited, and that endometriosis’s role in directly accelerating atherosclerotic plaque formation requires further elucidation.
  • The paper identifies a research gap in diagnostic tools that assess cardiovascular risk specifically in women with endometriosis, and states that optimal treatment strategies for coexisting endometriosis and cardiovascular conditions are not well established, including long-term safety/efficacy of statins and metformin.
  • Evident from the text: this is a narrative review without a registered systematic protocol or meta-analytic synthesis, the search is limited to PubMed and Google Scholar, English-language publications from 2010–2024, and AI tools were used in article identification; causality cannot be established from the largely observational and case-report evidence discussed.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.3390/diagnostics15121458

Cites

38 of 38 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Figures

Figure 1 Mechanisms linking endometriosis with cardiovascular disease.
Figure 1 Mechanisms linking endometriosis with cardiovascular disease.CC BY · PubMed Central

Verification

Claims the paper makes

41 Valid · 6 Not valid · 29 Not checked · 18 Own results and interpretations

41 more claims · 21 with their cited sources checked

Create a free account to see all 94 claims and every source verdict.

See all claims — free account
  • It may state two separate claims as one. 40
  • Probably not a substantial claim. 12

Create a free account to see these claims.

Citations

Cites

Research works printed but not linked: 1

  1. Sarmast, 2019, Cardiac Involvement Resulting from Thoracic Endometriosis, Cardiovasc. Surg. Interv., 1, 1002

Cited by

See all 7

Metadata

Authors
Szpila, G., Szczotka, J., Suchodolski, A., & Szulik, M.
Affiliations
  • 4. Wojskowy Szpital Kliniczny z Polikliniką (PL)
  • Medical University of Silesia (PL)
Corresponding author
Szulik, Mariola
Venue
Diagnostics
Publisher
MDPI AG
Published
2025-06-08
Volume
15
Issue
12
Pages
1458
ISSN
2075-4418 (ISSN-L)
OpenAlex
W4411158352
Cited by
7
References
41
Citations by year
2026: 7
FWCI
0.97
Type
journal article
Language
en
Open access
Locations
  • Diagnostics (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Topics
  • Health Sciences › Medicine › Reproductive Medicine › Endometriosis Research and Treatment
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Disease and Adiposity
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Infective Endocarditis Diagnosis and Management
Keywords
endometriosis, cardiovascular disease, atherosclerosis, systemic inflammation, endothelial dysfunction, oxidative stress, metabolic dysfunction, diaphragmatic endometriosis, inflammatory cytokines, statins, metformin, antiplatelet agents, cardiovascular risk assessment, multidisciplinary care

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

The claim verdicts this report counts are experimental: their accuracy is not yet measured.

A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (gpt-6-sol).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.